New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
12:13 EDTELOSSyneron Medical recommend following FDA clearance at Maxim
Maxim recommends investors continue buying shares of Syneron Medical following the FDA clearance of UltraShape. Maxim says UltraShape expands the base of body shaping treatments that physicians may use with complimentary Syneron systems and it keeps a Buy rating on the stock with a $16 price target.
News For ELOS From The Last 14 Days
Check below for free stories on ELOS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 15, 2014
10:35 EDTELOSSyneron Medical to host investor meeting
Investor meeting to be held in New York on September 17 at 10 am. Webcast Link
September 12, 2014
08:01 EDTELOSSyneron Medical management to meet with Leerink
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use